New Frontiers in Neuroendocrine Tumors: Enhancing Diagnosis, Treatment, and Patient Outcomes
Journal of the Advanced Practitioner in Oncology · 27.02.2026 · 17 (2)
DOI: 10.6004/jadpro.2026.17.2.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 27.02.2026. Verfasst von Paula S. Kennedy-Newton und 2 weiteren Autor:innen.
Abstract (Originalsprache)
At JADPRO Live 2025, Paula S. Kennedy-Newton, MSN, AGNP-C, discussed the underlying pathophysiology of neuroendocrine tumors (NETs), clinical presentation, diagnostic evaluation, the mechanisms of action and safety/efficacy data for NET therapies, and multidisciplinary care models to address the complex medical and psychosocial needs of patients living with NETs.
Zitieren
APA
Kennedy-Newton, P. S., MSN, & AGNP-C (2026). New Frontiers in Neuroendocrine Tumors: Enhancing Diagnosis, Treatment, and Patient Outcomes. Journal of the Advanced Practitioner in Oncology, 17(2). https://doi.org/10.6004/jadpro.2026.17.2.11
Vancouver
Kennedy-Newton PS, MSN, AGNP-C. New Frontiers in Neuroendocrine Tumors: Enhancing Diagnosis, Treatment, and Patient Outcomes. Journal of the Advanced Practitioner in Oncology. 2026;17(2). doi:10.6004/jadpro.2026.17.2.11
BibTeX
@article{KennedyNewton2026,
author = {Kennedy-Newton, Paula S. and MSN and AGNP-C},
title = {New Frontiers in Neuroendocrine Tumors: Enhancing Diagnosis, Treatment, and Patient Outcomes},
journal = {Journal of the Advanced Practitioner in Oncology},
year = {2026},
volume = {17},
number = {2},
doi = {10.6004/jadpro.2026.17.2.11}
}
EUVIMED